在巨细胞中激活PPARα通过抑制YAP核定位来减弱动脉重塑
Xinxin Lin1, Xiaocong Liu2, Jinglin Shi2
1Department of Cardiology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Baiyun District, Guangzhou 510515, China; Department of Critical Care Medicine, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, Fuzhou 350005, China.
过氧体增殖器激活受体α (PPARα) 的激活通过抑制巨细胞透来减少动脉重塑. 这一发现凸显了PPARα作为心血管疾病的潜在治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 炎症研究 炎症研究
背景情况:
- 动脉改造对心血管发病率和死亡率作出了重大贡献.
- 进发性炎症是病理性动脉重塑的关键因素,但其分子驱动因素尚未完全理解.
研究的目的:
- 研究过氧体增殖器激活受体α (PPARα) 在动脉重塑中的作用和机制.
- 探索PPARα作为心血管疾病治疗点的潜力.
主要方法:
- 利用横向大动脉收缩 (TAC) 模型来诱导压力过载动脉重塑.
- 服用PPARα激动剂 (Wy14643) 并评估其对动脉重塑和随机炎症的影响.
- 研究了PPARα与巨细胞中YAP信号通路之间的相互作用.
主要成果:
- TAC模型显示在偶然性巨细胞中PPARα表达的降低.
- 治疗改善了动脉重塑,特别是随机变化.
- PPARα激活抑制了YAP核转位,减少了巨细胞透和M1极化.
- YAP信号封锁也抑制了病理性动脉变化.
结论:
- PPARα激活通过通过YAP信号调节巨细胞行为来缓解动脉重塑.
- PPARα代表了治疗动脉改造和相关心血管疾病的有前途的治疗标.
更多相关视频
07:36Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
相关概念视频
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Inflammation
GPCRs Regulate Adenylyl Cylase Activity
cAMP-dependent Protein Kinase Pathways
